A Clinical Evaluation of the RheOx Bronchial Rheoplasty System
NCT: NCT05641207 · COMPLETED
NCT IDNCT05641207
StatusCOMPLETED
Start Date2023-05-18
Completion2026-06-30
SponsorEnergenx Medical LTD. (INDUSTRY)
First posted
Last updated
Brief Summary
This is a prospective, multicenter, single arm and open-label clinical trial to evaluate the performance, effectiveness and safety of RheOx™ system in the treatment of the symptoms of chronic bronchitis in adult moderate to severe COPD patients.
Frequently Asked Questions
What is A Clinical Evaluation of the RheOx Bronchial Rheoplasty System?
A Clinical Evaluation of the RheOx Bronchial Rheoplasty System is a clinical trial registered under NCT05641207. Current status: COMPLETED.
What is the status of NCT05641207?
The current status of NCT05641207 (A Clinical Evaluation of the RheOx Bronchial Rheoplasty System) is: COMPLETED.
When did A Clinical Evaluation of the RheOx Bronchial Rheoplasty System start?
A Clinical Evaluation of the RheOx Bronchial Rheoplasty System started on 2023-05-18.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.